Second-line treatment of non-small cell lung cancer: Big targets, small progress; small targets, big progress?

Research output: Contribution to journalEditorial

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)927-928
Number of pages2
JournalJournal of Thoracic Oncology
Volume1
Issue number9
DOIs
StatePublished - Nov 1 2006

Fingerprint

Benzenesulfonates
Antineoplastic Combined Chemotherapy Protocols
Piperidines
Glutamates
Quinazolines
Pyridines
Taxoids
Phase II Clinical Trials
Guanine
Survival Analysis
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Randomized Controlled Trials
Monoclonal Antibodies

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Second-line treatment of non-small cell lung cancer : Big targets, small progress; small targets, big progress? / Hanna, Nasser.

In: Journal of Thoracic Oncology, Vol. 1, No. 9, 01.11.2006, p. 927-928.

Research output: Contribution to journalEditorial

@article{aae9a1e228e941388b2555144a5d96ca,
title = "Second-line treatment of non-small cell lung cancer: Big targets, small progress; small targets, big progress?",
author = "Nasser Hanna",
year = "2006",
month = "11",
day = "1",
doi = "10.1097/01243894-200611000-00001",
language = "English (US)",
volume = "1",
pages = "927--928",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "9",

}

TY - JOUR

T1 - Second-line treatment of non-small cell lung cancer

T2 - Big targets, small progress; small targets, big progress?

AU - Hanna, Nasser

PY - 2006/11/1

Y1 - 2006/11/1

UR - http://www.scopus.com/inward/record.url?scp=34247897225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247897225&partnerID=8YFLogxK

U2 - 10.1097/01243894-200611000-00001

DO - 10.1097/01243894-200611000-00001

M3 - Editorial

C2 - 17409973

AN - SCOPUS:34247897225

VL - 1

SP - 927

EP - 928

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 9

ER -